A novel high-throughput, real time imaging platform to assess immunogenic cell killing activity

A novel high-throughput, high-content real time imaging platform to assess immunogenic cell killing activity of immunotherapeutic agents using patient-derived tumor samples

Melanie Mediavilla Varela, Melba Marie Page, Jenny Kreahling, Scott Antonia and Soner Altiok, Nilogen Oncosystems, H. Lee Moffitt Cancer Center. The Society for Immunotherapy of Cancer (SITC). 11/08/2017 to 11/12/17. National Harbor, MD, USA.

DOWNLOAD poster